Headlines
-
97.2% of pharmacists compliant
Monday | May 13 2019PHARMACISTS have a higher level of compliance than other professions the Australian Health Practitioner Regulation Agency (AHPRA) audit data reveals.
-
Sustainable opioid plan
Monday | May 13 2019AUSTRALIA needs to adopt an approach that ensures sustainable access to opioids for patients in palliative care, according to Painaustralia CEO Carol Bennett.
-
Closing the pharmacy gap
Friday | May 10 2019ENSURING Indigenous Australians have comprehensive access to pharmacy services must be regarded as a minimum for any incoming Federal Government, according to the Pharmacy Guild.
-
ACCC ticks GSK-Pfizer deal
Friday | May 10 2019THE Australian Competition and Consumer Commission (ACCC) has confirmed it will not oppose the proposed acquisition of Pfizer's consumer healthcare business in Australia by GlaxoSmithKline (GSK) (PD breaking news yesterday).
-
Vax “a lost opportunity”
Thursday | May 9 2019PHARMACISTS are missing out by not providing vaccination services, University of Technology Sydney Community Pharmacy Barometer expert panel member, John Montgomery, says.
-
Instigo celebrates excellence
Thursday | May 9 2019MORE than 100 delegates gathered in Melbourne last week for Instigo's ninth annual Pharmacy Catalyst Conference.
-
Queensland’s low vax rate
Thursday | May 9 2019QUEENSLAND is dragging the chain when it comes to vaccination rates, with the Sunshine Coast and Gold Coast hinterlands having the worst childhood vaccination rates in the state, according to the Australian Immunisation Register.
-
Pharmacist/GP harmony
Thursday | May 9 2019PHARMACISTS and general practitioners enjoy largely constructive relationships, the University of Technology Sydney (UTS) Pharmacy Barometer reveals.
-
Pharmacy confidence rising
Wednesday | May 8 2019PHARMACY owners' confidence in the future viability of the profession is on the rise, the 2018 University of Technology Sydney (UTS) Pharmacy Barometer reveals.
-
MedAdvisor-Zuellig deal
Wednesday | May 8 2019LISTED digital medicines management company MedAdvisor and healthcare services group Zuellig Pharma have announced they have finalised the formation of a Singapore based 50:50 joint venture establishing a new entity called ZP MedAdvisor Pte Ltd (ZPM).